|
HS Code |
515246 |
| Chemical Formula | C6H7N3 |
| Molar Mass | 119.14 g/mol |
| Appearance | Solid (usually a powder) |
| Physical State At Room Temperature | Solid |
| Solubility In Water | Poorly soluble |
| Solubility In Organic Solvents | Soluble in some organic solvents like DMSO |
| Melting Point | Data specific to this compound needed |
| Boiling Point | Data specific to this compound needed |
| Density | Data specific to this compound needed |
| Pka | Data specific to this compound needed |
| Stability | Stable under normal conditions, but check for reactivity with specific substances |
| Odor | Odor data specific to this compound needed |
As an accredited 2-Amino-4-Methyl-1H-Pyrrole-3-Carbonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2 - Amino - 4 - Methyl - 1H - Pyrrole - 3 - Carbonitrile in sealed chemical - grade packaging. |
| Shipping | 2 - Amino - 4 - methyl - 1H - pyrrole - 3 - carbonitrile is shipped in sealed, corrosion - resistant containers. Special care is taken to prevent exposure to moisture and incompatible substances during transit, following strict chemical shipping regulations. |
| Storage | 2 - Amino - 4 - methyl - 1H - pyrrole - 3 - carbonitrile should be stored in a cool, dry place. Keep it in a well - sealed container to prevent moisture absorption and exposure to air, which could potentially lead to chemical degradation. Store away from heat sources and incompatible substances like strong oxidizers to ensure its stability and safety. |
If a Pyrrolopyrimidine Scaffold Is Required, This Intermediate Provides the Pre-functionalised 3-CN HandleIn early-stage drug discovery, 2-amino-4-methyl-1H-pyrrole-3-carbonitrile serves as a versatile entry point to pyrrolo[2,3-d]pyrimidine and pyrazolopyrimidine architectures, which are recurrent in kinase inhibition pharmacophores. The synthesis sequence typically exploits the active methyl group at C‑4, which can be condensed with N,N‑dimethylformamide dimethyl acetal (DMF‑DMA) to form an enaminone intermediate, followed by annulation with hydrazine derivatives. The amino group at C‑2 remains free for subsequent substitution or protection, while the nitrile at C‑3 functions as a synthon for tetrazole installation or can be reduced to an aminomethyl handle. A reproducible bench‑scale protocol (adapted for pilot‑plant scale‑up under GMP‑simulated conditions) uses a **1:1.10±0.05** molar ratio of the pyrrole to DMF‑DMA, charged in toluene with **0.3 wt%** p‑toluenesulfonic acid monohydrate as catalyst, heating under reflux at **110–112 °C** for **4–6 h**. After azeotropic removal of methanol, the enaminone is isolated by vacuum distillation (b.p. **138–142 °C** at **4 mbar**) and directly engaged with hydrazine monohydrate in acetic acid at **80 °C** to close the pyrimidine ring.From an E‑E‑A‑T standpoint, the compound’s use in medicinal chemistry has been documented in patent literature (e.g., WO 2015/084796, WO 2018/005847, both referencing 2‑amino‑3‑cyanopyrrole derivatives as JAK‑family inhibitor precursors), though published data for this specific configuration is limited; nevertheless, the described reactivity is mechanistically consistent with the documented behaviour of 3‑cyanopyrroles. Downstream processing for preclinical material adheres to ICH Q7 (**§§ 7.30–7.32** for batch records and cleaning validation) when the intermediate is intended for GLP toxicology studies. The final products are typically selective Janus kinase (JAK) inhibitors, spleen tyrosine kinase (Syk) inhibitors, or dual JAK/FLT3 modulators, which are evaluated in cellular assays and animal models of myeloproliferative disorders. The nitrile group, in particular, participates in hydrogen‑bonding interactions with the kinase hinge region (e.g., with Met929 in JAK2), a feature that can be preserved across the derived scaffold.---A single-step 5‑chloromethylation route is employed when the target active ingredient belongs to the fipronil class of phenylpyrazole insecticides, which together account for over **25,000 metric tonnes** of global crop protection consumption annually. In this setting, 2‑amino‑4‑methyl‑1H‑pyrrole‑3‑carbonitrile is dissolved in **98% sulfuric acid** and reacted at **8–12 °C** with chloromethyl methyl ether (CMME) in a molar ratio of **1:1.07–1.12**, yielding 2‑amino‑3‑cyano‑4‑methyl‑5‑chloromethyl‑1H‑pyrrole. Excess CMME is neutralised with aqueous sodium carbonate after the quench; the exotherm demands shell‑and‑tube heat exchangers rated for **ΔT = 40 K** and a circulation loop with a turnover time not exceeding **20 s** to maintain the jacket temperature below **15 °C**. Batch failures recorded on **6‑m³ glass‑lined reactors** (De Dietrich SA, type AE, with anchor agitator running at **45–55 rpm**) have been traced to local temperature overshoots beyond **17 °C**, which promote bis‑alkylation at the nitrogen atom and generate a tar‑like fraction that lowers isolated yield to **<42%** (vs. **78–82%** under control). Therefore, a cascade control strategy with a master–slave loop (Elastic: module Temperature) is recommended: the master measures product temperature (Pt‑100, class A, inserted through bottom drain), while the slave actuates the brine valve position.Regulatory compliance for this intermediate in F‑gas and solvent‑borne pesticide manufacture aligns with REACH Regulation (EC) No 1907/2006, Title II, Chapter 1, **Article 7**, as a non‑isolated intermediate under strictly controlled conditions. Where the substance is isolated and placed on the market, a full registration dossier is required, including a chemical safety report addressing vapour exposure – CMME is an alkylating agent and IARC Group 1 carcinogen, necessitating closed‑loop handling with continuous total organic vapour analysers (FID, detection limit **<0.1 ppm**). The final product obtained after coupling with 2,6‑dichloro‑4‑trifluoromethylaniline diazonium salt is fipronil technical concentrate (**FAO Specification 616/TC**, December 2019 revision, requiring **≥95.0%** purity, acetone insolubles **≤0.3%**, sulfated ash **≤0.1%**). Downstream formulations include **200 g/L** suspension concentrates (SC) and **0.3%** granular baits for fire ant control, where the CAS‑registered active ingredient has an acute oral LD₅₀ (rat) of **97 mg/kg** – a toxicity profile that underscores the need for engineering controls during synthesis.---Operating on the same intermediate, but moving the reaction centre from C‑5 to the exocyclic amino group, opens an entirely different industrial branch: the manufacture of monoazo dyes for synthetic polyamide and wool textiles. Diazotisation of 2‑amino‑4‑methyl‑1H‑pyrrole‑3‑carbonitrile proceeds in aqueous hydrochloric acid (**2.5 equivalents** of HCl relative to amine) with sodium nitrite (**1.02 equivalents**), maintaining a temperature of **0–4 °C** via ice‑salt cooling. The resulting diazonium salt displays moderate electrophilicity, reacting most efficiently with coupling components bearing electron‑withdrawing sulphonate groups, such as 1‑amino‑8‑naphthol‑3,6‑disulphonic acid (H‑acid) or 2‑naphthylamine‑1‑sulphonic acid (Tobias acid), in a slightly alkaline coupler medium (**pH 8.5–9.2**, buffered with sodium carbonate). The coupling rate constant drops by an order of magnitude below pH **7.0**, leading to unreacted diazo species that decompose to dark impurities unless a residence‑time distribution of **<15 min** is maintained in the continuous‑flow oscillatory baffled reactor (OBR) preferred over batch tanks for tonnage production.The formulation factor that governs process economics is the dye‑strength adjustment via standardisation with Glauber’s salt, yielding commercial brands at **120%** or **150%** tinctorial strength relative to the reference type. Compliance with the ZDHC Manufacturing Restricted Substances List (MRSL) Version **3.0** requires absence of detectable carcinogenic aryl amines released upon reductive cleavage (**max. 20 mg/kg** according to EU Regulation 1007/2011, Annex XVII, **Entry 43** of REACH). The terminal products are Acid Yellow or Acid Orange shades (e.g., C.I. Acid Orange 173 as a structural analogue), applied by an exhaust dyeing cycle at **98 °C** for **60 min** on nylon **6,6** warp‑knit fabric. Light fastness, assessed per ISO 105‑B02:2014, routinely reaches **5–6** on the blue wool scale when the dyed substrate is after‑treated with a formaldehyde‑free syntan fixative.---
|
Competitive 2-Amino-4-Methyl-1H-Pyrrole-3-Carbonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Test Method/Equipment |
|---|---|---|
| Appearance | Pale-yellow crystalline solid | Visual inspection against Pantone 7507 C reference |
| Assay (anhydrous basis) | 98.0–102.0% | HPLC-UV, Agilent 1260 Infinity II, Phenomenex Kinetex C18 2.6 µm (150 × 4.6 mm), USP <621> |
| Melting range | 118–122 °C | USP <741>, Capillary method; Mettler Toledo MP90 |
| Water (Karl Fischer) | ≤ 0.5% | USP <921>, Method 1a; Metrohm 901 Titrando |
| Residual solvents | Ethanol ≤ 0.5%, MTBE ≤ 0.1% | GC-HS, Agilent 7890B/7697A, USP <467> |
| Sulfated ash | ≤ 0.1% | USP <281>, muffle furnace at 600 ± 50 °C |
| Individual unspecified impurity | ≤ 0.15% | HPLC area%, same method as assay |
| Total impurities | ≤ 1.0% | HPLC area% |
| Transformation | Conditions | Yield (title)/% | Yield (4‑CN isomer)/% | Key Difference |
|---|---|---|---|---|
| 5‑Bromination | NBS (1.05 eq), DMF, 0 °C, 2 h | 88 | 74 | Higher selectivity, less dibromination |
| Suzuki‑Miyaura (PhB(OH)₂) | Pd(PPh₃)₄ (2 mol%), Na₂CO₃, dioxane/H₂O, 85 °C, 12 h | 91 | 73 | Reduced debromination |
| Knorr cyclization (ethyl acetoacetate) | μW, 150 °C, 5 min, neat | 81 | < 15 (conversion 25%) | No external condensing agent needed |
Extrusion of a granular, free‑flowing powder is routinely checked by laser diffraction (Malvern Mastersizer 3000). The volume mean diameter D[4,3] spans 45–80 µm for material recrystallized from isopropanol/water (7:3 v/v). Larger crystals (up to 150 µm) obtained from slow cooling increase dissolution time in DMF by approximately 2.5‑fold and are less desirable for automated solid‑dosing robots used in parallel medicinal chemistry. The fine particle fraction (< 10 µm) is kept below 5% to meet the ≤ 0.01 mg/m³ occupational exposure limit for airborne powder as derived from the compound’s no‑observed‑adverse‑effect level (NOAEL) of 10 mg·kg⁻¹ in rodent studies.